Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 1
2010 3
2011 7
2012 2
2013 5
2014 2
2015 4
2016 1
2018 1
2019 5
2020 4
2021 1
2022 4
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Niveau de preuve du suivi thérapeutique pharmacologique du lopinavir.
Barrail-Tran A, Taburet AM, Poirier JM; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Barrail-Tran A, et al. Therapie. 2011 May-Jun;66(3):231-8. doi: 10.2515/therapie/2011034. Therapie. 2011. PMID: 27393203 French.
Niveau de preuve du suivi thérapeutique pharmacologique de l'indinavir.
Barrail-Tran A, Taburet AM, Poirier JM; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Barrail-Tran A, et al. Therapie. 2011 May-Jun;66(3):239-46. doi: 10.2515/therapie/2011035. Therapie. 2011. PMID: 27393204 French.
[Evidence-based therapeutic drug monitoring of lopinavir].
Barrail-Tran A, Taburet AM, Poirier JM; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Barrail-Tran A, et al. Therapie. 2011 May-Jun;66(3):231-8. doi: 10.2515/therapie/2011034. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819807 Review. French.
Specific Biological Features of Adipose Tissue, and Their Impact on HIV Persistence.
Bourgeois C, Gorwood J, Barrail-Tran A, Lagathu C, Capeau J, Desjardins D, Le Grand R, Damouche A, Béréziat V, Lambotte O. Bourgeois C, et al. Among authors: barrail tran a. Front Microbiol. 2019 Dec 17;10:2837. doi: 10.3389/fmicb.2019.02837. eCollection 2019. Front Microbiol. 2019. PMID: 31921023 Free PMC article. Review.
[Evidence-based therapeutic drug monitoring for indinavir].
Barrail-Tran A, Taburet AM, Poirier JM; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Barrail-Tran A, et al. Therapie. 2011 May-Jun;66(3):239-46. doi: 10.2515/therapie/2011035. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819808 Review. French.
Raltegravir Pharmacokinetics in Patients on Asunaprevir-Daclatasvir.
Barrail-Tran A, Vincent C, Furlan V, Rosa I, Rosenthal E, Cheret A, Molina JM, Taburet AM, Piroth L; ANRS HC30 QUADRIH Study Group. Barrail-Tran A, et al. Antimicrob Agents Chemother. 2015 Dec;59(12):7903-5. doi: 10.1128/AAC.01603-15. Epub 2015 Oct 5. Antimicrob Agents Chemother. 2015. PMID: 26438504 Free PMC article.
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.
Passaes C, Desjardins D, Chapel A, Monceaux V, Lemaitre J, Mélard A, Perdomo-Celis F, Planchais C, Gourvès M, Dimant N, David A, Dereuddre-Bosquet N, Barrail-Tran A, Gouget H, Guillaume C, Relouzat F, Lambotte O, Guedj J, Müller-Trutwin M, Mouquet H, Rouzioux C, Avettand-Fenoël V, Le Grand R, Sáez-Cirión A. Passaes C, et al. Among authors: barrail tran a. Nat Commun. 2024 Jan 11;15(1):178. doi: 10.1038/s41467-023-44389-3. Nat Commun. 2024. PMID: 38212337 Free PMC article.
40 results